Detection of hypoxia in human squamous cell carcinoma by EF5 binding. [electronic resource]
Producer: 20000504Description: 2018-24 p. digitalISSN:- 0008-5472
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Binding Sites
- Carcinoma, Squamous Cell -- drug therapy
- Cell Hypoxia
- Etanidazole -- adverse effects
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Hydrocarbons, Fluorinated -- adverse effects
- Male
- Middle Aged
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.